EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudie

Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: Results of a multicenter, retrospective cohort study

Lisa M Arkin, Kevin A Buhr, Stacy P Ardoin, Esteban Fernandez Faith, Lara Wine Lee, Emily von Scheven, J Heather Brandling-Bennett, Leslie Castelo-Soccio, Yvonne E Chiu, Dominic O Co, Lucia Z Diaz, Maria T Garcia-Romero und 9 weitere

Journal of the American Academy of Dermatology · 2026

DOI: 10.1016/j.jaad.2026.06.045 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Lisa M Arkin und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Wisconsin School of Medicine, Madison, Wisconsin. Electronic address: larkin@dermatology.wisc.edu. Hauptthemen laut MEDLINE: Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic. Die Arbeit nennt 34 Literaturangaben. Gefördert von: CARRA Inc, PeDRA, Arthritis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pediatric skin-limited discoid lupus erythematosus (DLE-only) is rare, with limited data on risk factors for progression to systemic lupus erythematosus (SLE). OBJECTIVE: To assess incidence, risk factors, and phenotype of pediatric DLE-only progression to SLE. METHODS: In this 17-site retrospective cohort of pediatric DLE, the primary outcome was time to SLE diagnosis (American College of Rheumatology classification criterion ≥4). Kaplan-Meier estimates for 1-, 2-, and 5-year progression to SLE were generated. Cox proportional hazards modeling identified baseline predictors of progression to SLE. RESULTS: The 1-year progression rate from DLE-only to SLE was 14.4% (95% CI, 9.6-18.9). Progression to SLE was most strongly associated with baseline antinuclear antibody positivity (hazard ratio, 3.71) and older age (hazard ratio, 1.11/y). Antiphospholipid antibodies and cytopenias also predicted progression to SLE in multivariable analysis. The SLE phenotype was relatively mild, with most patients meeting mucocutaneous and laboratory criteria (22/236, 9%) and a few patients in whom other end-organ diseases developed (7/236, 3%). LIMITATIONS: Retrospective design, missing data. CONCLUSION: Antinuclear antibody-positive patients with DLE-only warrant close monitoring for progression to SLE, especially within the first year. Severe end-organ disease in patients with DLE who progress to SLE is uncommon. Future studies should test whether early recognition and intervention in DLE-only slows progression to SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, DiscoidLupus Erythematosus, SystemicAdolescentChildChild, PreschoolFemaleHumansMaleAntibodies, AntinuclearCohort StudiesDisease ProgressionIncidenceKaplan-Meier EstimateProportional Hazards ModelsRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

discoid lupus erythematosussystemic lupus erythematosus

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Dermatology, University of Wisconsin School of Medicine, Madison, Wisconsin. Electronic address: larkin@dermatology.wisc.edu.
  • Department of Biostatistics & Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Division of Dermatology and Rheumatology, Department of Pediatrics, Nationwide Children's Hospital/Ohio State University, Columbus, Ohio.
  • Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.
  • Division of Rheumatology, Department of Pediatrics, University of California at San Francisco, San Francisco, California.
  • Division of Dermatology, Department of Pediatrics, Seattle Children's Hospital/University of Washington School of Medicine, Seattle, Washington.

Förderung

  • CARRA Inc
  • PeDRA
  • Arthritis Foundation

Zitieren

APA

Arkin, L. M., Buhr, K. A., Ardoin, S. P., Faith, E. F., Lee, L. W., von Scheven, E., Brandling-Bennett, J. H., Castelo-Soccio, L., Chiu, Y. E., Co, D. O., Diaz, L. Z., Garcia-Romero, M. T., Hunt, R. D., Oza, V. S., Schoch, J. J., Paller, A. S., Vleugels, R. A., Chong, B. F., Werth, V. P., …, & CARRA-PeDRA Lupus Dermatology Work Group (2026). Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: Results of a multicenter, retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.06.045

Vancouver

Arkin LM, Buhr KA, Ardoin SP, Faith EF, Lee LW, von Scheven E, et al. Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: Results of a multicenter, retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.06.045

BibTeX
@article{Arkin2026,
  author = {Arkin, Lisa M and Buhr, Kevin A and Ardoin, Stacy P and Faith, Esteban Fernandez and Lee, Lara Wine and von Scheven, Emily and Brandling-Bennett, J Heather and Castelo-Soccio, Leslie and Chiu, Yvonne E and Co, Dominic O and Diaz, Lucia Z and Garcia-Romero, Maria T and Hunt, Reagan D and Oza, Vikash S and Schoch, Jennifer J and Paller, Amy S and Vleugels, Ruth Ann and Chong, Benjamin F and Werth, Victoria P and Ardalan, Kaveh and CARRA-PeDRA Lupus Dermatology Work Group, CARRA-PeDRA Lupus Dermatology Work Group},
  title = {Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: Results of a multicenter, retrospective cohort study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.06.045}
}
Kostenlos starten →